Aurinia Pharmaceuticals (AUPH) Amortization of Deferred Charges (2021 - 2023)
Aurinia Pharmaceuticals (AUPH) posted Amortization of Deferred Charges of $99000.0 for Q2 2023, up 5.32% on a QoQ basis from $94000.0 in Q1 2023, and down 35.29% year-over-year from $153000.0 in Q2 2022.
Aurinia Pharmaceuticals (AUPH) Amortization of Deferred Charges (2021 - 2023) Analysis & Trends
Aurinia Pharmaceuticals' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $99000.0 for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.07 Bn | 1.69 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 99,000.00 |
| Jun 30, 2023 | 99,000.00 |
| Mar 31, 2023 | 94,000.00 |
| Mar 31, 2023 | 94,000.00 |
| Jun 30, 2022 | 153,000.00 |
| Jun 30, 2022 | 153,000.00 |
| Mar 31, 2022 | 151,000.00 |
| Mar 31, 2022 | 151,000.00 |
| Mar 31, 2021 | -272,000.00 |
| Mar 31, 2021 | -272,000.00 |